ID PTLCB_STAHJ Reviewed; 583 AA. AC Q4L869; DT 20-DEC-2005, integrated into UniProtKB/Swiss-Prot. DT 02-AUG-2005, sequence version 1. DT 16-JUN-2009, entry version 32. DE RecName: Full=PTS system lactose-specific EIICB component; DE AltName: Full=EIICB-Lac; DE Short=EII-Lac; DE Includes: DE RecName: Full=Lactose permease IIC component; DE AltName: Full=PTS system lactose-specific EIIC component; DE Includes: DE RecName: Full=Lactose-specific phosphotransferase enzyme IIB component; DE EC=2.7.1.69; DE AltName: Full=PTS system lactose-specific EIIB component; GN Name=lacE; OrderedLocusNames=SH0847; OS Staphylococcus haemolyticus (strain JCSC1435). OC Bacteria; Firmicutes; Bacillales; Staphylococcus. OX NCBI_TaxID=279808; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16237012; DOI=10.1128/JB.187.21.7292-7308.2005; RA Takeuchi F., Watanabe S., Baba T., Yuzawa H., Ito T., Morimoto Y., RA Kuroda M., Cui L., Takahashi M., Ankai A., Baba S., Fukui S., RA Lee J.C., Hiramatsu K.; RT "Whole-genome sequencing of Staphylococcus haemolyticus uncovers the RT extreme plasticity of its genome and the evolution of human-colonizing RT staphylococcal species."; RL J. Bacteriol. 187:7292-7308(2005). CC -!- FUNCTION: The phosphoenolpyruvate-dependent sugar CC phosphotransferase system (sugar PTS), a major carbohydrate active CC -transport system, catalyzes the phosphorylation of incoming sugar CC substrates concomitantly with their translocation across the cell CC membrane. This system is involved in lactose transport. CC -!- CATALYTIC ACTIVITY: Protein EIIB N(pi)-phospho-L- CC histidine/cysteine + sugar = protein EIIB + sugar phosphate. CC -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein CC (Probable). CC -!- DOMAIN: The EIIC domain forms the PTS system translocation channel CC and contains the specific substrate-binding site. CC -!- DOMAIN: The EIIB domain is phosphorylated by phospho-EIIA on a CC cysteinyl or histidyl residue, depending on the transported sugar. CC Then, it transfers the phosphoryl group to the sugar substrate CC concomitantly with the sugar uptake processed by the EIIC domain. CC -!- SIMILARITY: Contains 1 PTS EIIB type-3 domain. CC -!- SIMILARITY: Contains 1 PTS EIIC type-3 domain. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AP006716; BAE04156.1; -; Genomic_DNA. DR RefSeq; YP_252762.1; -. DR GeneID; 3482144; -. DR GenomeReviews; AP006716_GR; SH0847. DR KEGG; sha:SH0847; -. DR NMPDR; fig|279808.3.peg.860; -. DR HOGENOM; Q4L869; -. DR OMA; Q4L869; WSKDIEN. DR BioCyc; SHAE279808:SH0847-MON; -. DR GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW. DR GO; GO:0008982; F:protein-N(PI)-phosphohistidine-sugar phosph...; IEA:EC. DR GO; GO:0005529; F:sugar binding; IEA:InterPro. DR GO; GO:0005351; F:sugar:hydrogen symporter activity; IEA:UniProtKB-KW. DR GO; GO:0009401; P:phosphoenolpyruvate-dependent sugar phospho...; IEA:UniProtKB-KW. DR InterPro; IPR014350; PTrfase_system_EIIB_3_subgr. DR InterPro; IPR013012; PTS_EIIB_3. DR InterPro; IPR003352; PTS_EIIC. DR InterPro; IPR003501; PTS_IIB_lac. DR InterPro; IPR004501; PTS_IIC_lac. DR InterPro; IPR004801; PTS_IIC_lac_spec. DR Pfam; PF02378; PTS_EIIC; 1. DR Pfam; PF02302; PTS_IIB; 1. DR TIGRFAMs; TIGR00394; lac_pts_IIC; 1. DR TIGRFAMs; TIGR00410; lacE; 1. DR TIGRFAMs; TIGR00853; pts-lac; 1. DR PROSITE; PS51100; PTS_EIIB_TYPE_3; 1. DR PROSITE; PS51105; PTS_EIIC_TYPE_3; 1. PE 4: Predicted; KW Cell membrane; Complete proteome; Kinase; Membrane; KW Phosphotransferase system; Sugar transport; Transferase; KW Transmembrane; Transport. FT CHAIN 1 583 PTS system lactose-specific EIICB FT component. FT /FTId=PRO_0000186594. FT TRANSMEM 29 49 Potential. FT TRANSMEM 60 80 Potential. FT TRANSMEM 101 121 Potential. FT TRANSMEM 130 150 Potential. FT TRANSMEM 173 193 Potential. FT TRANSMEM 218 238 Potential. FT TRANSMEM 277 297 Potential. FT TRANSMEM 333 353 Potential. FT TRANSMEM 374 394 Potential. FT DOMAIN 480 583 PTS EIIB type-3. FT ACT_SITE 487 487 Phosphocysteine intermediate; for EIIB FT activity (By similarity). SQ SEQUENCE 583 AA; 64211 MW; DCBDAECEF9CB5654 CRC64; MNKLIAWIEK GKPFFEKISR NIYLRAIRDG FIAAIPIILF SSIFILITYV PNVFGFTWSK TMEGILMKPY NYTMGIVGLI VAGTTAKSLT DSYNRKLDKT NQINFISTMM AAMSGFLFLA ADPIKEGGFL SAFMGTKGLL TAFISAFITV IVYNFFIKRN ITIKMPKEVP PNISQVFKDI FPLSAVIIII YALDLLSRTF IHTNVANAVL KIFEPLFTAA DGWIGVTLIF GAFAFFWFVG IHGPSIVEPA IAAITYANLE TNLNLIQAGE HADKIITPGT QMFVATMGGT GATLVVPFMF MWLTKSKRNK AIGRASVVPT FFGVNEPILF GAPLVLNPVF FIPFIFAPIV NVWIFKFFVD VLKMNSFSIF LPWTTPGPLG IVMGTGFAFW SFVLAIVLIV VDVMIYYPFL KVYDEQILEE ERGNKEVNNE LKEKVSANFD TKKADAILAT AGANETTTTE SAPSDEEVSA KNSSNSINEQ TNVLVLCAGG GTSGLLANAL NKAAEEYQVP VKAAAGGYGA HMDIMKDYQL IILAPQVASN YEDIKQDTDR LGIKLAKTQG VEYINLTRDG KAALDFVQQQ FEK //